Douglas Insights

Leading Companies in the solid tumor cancer treatment market are AstraZeneca, Amgen, B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company

DOUGLAS, ISLE OF MAN, October 28, 2022 /EINPresswire.com/ -- The global solid tumor cancer treatment market is expected to reach US$ 424.6 Bn by 2027 from US$ 121.3 Bn in 2018, at a CAGR of 15%. The rising prevalence of cancer, technological advancements in cancer treatments, and the increasing number of government initiatives to create awareness about early cancer detection are the major factors driving the growth of this market. However, the high cost of treatment and the side effects associated with cancer treatments are restraining the growth of this market. The report segments the solid tumor cancer treatment market into type, therapy type, and geography.

What is Solid Tumor Cancer Treatment?

Solid tumor cancer is a type of cancer that begins in the solid tissues of the body. The most common solid tumors are breast, colon, lung, and prostate cancer. Treatment for solid tumors usually involves surgery, radiation therapy, or chemotherapy.

Surgery is the most common treatment for solid tumors. The goal of surgery is to remove the tumor and any surrounding tissue that may contain cancer cells. Radiation therapy uses high-energy beams to kill cancer cells. Radiation therapy can be used before or after surgery to kill any remaining cancer cells. Chemotherapy uses drugs to kill cancer cells. Chemotherapy can be used before or after surgery to kill any remaining cancer cells.

Solid Tumor Cancer Treatment Market Size and COVID-19 Impact Analysis:

The global solid tumor cancer treatment market was valued at around US$ 121.3 Bn in 2018 and is expected to reach around US$ 424.6 Bn by 2027, growing at a CAGR of 15% between 2020 and 2027. The report provides a detailed analysis of the global solid tumor cancer treatment market based on drug type, indication, distribution channel, and geography.

According to the most recent data presented by the World Health Organization (WHO) in 2018, approximately 9.6 million people are estimated to die from cancer; they also claim that 30 to 50 percent of cancers can be prevented through early detection and effective treatment.
COVID-19 has had a profound impact on the solid tumor cancer treatment market. The pandemic has led to a decrease in the number of new cancer diagnoses and an increase in the number of deaths from the disease. This has resulted in a decrease in the demand for solid tumor cancer treatments and a corresponding decrease in revenue for the companies that produce these treatments.

The COVID-19 pandemic has also impacted clinical trials for new solid tumor cancer treatments. Many companies have delayed or canceled their clinical trials due to the pandemic. This has led to a slowdown in the development of new treatments for solid tumors, which will likely have a negative impact on the market in the long term.

Compare and choose your best-fitting market report here- https://douglasinsights.com/solid-tumor-cancer-treatment-market

Segments:

Global Solid Tumor Cancer Treatment (STCT) Market, by Indication
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others (Brain Tumor, Pancreatic Cancer etc.)

Global Solid Tumor Cancer Treatment (STCT) Market, by Therapy
Chemotherapy
Targeted Therapy
Immunotherapy
Hormone Therapy
Surgical Procedures

Solid Tumor Cancer Treatment Market Drivers and Restraints:

The global solid tumor cancer treatment market is primarily driven by the increasing prevalence of cancer and the availability of new and advanced treatments. The rising incidence of solid tumors, such as breast, ovarian, and colorectal cancer, is expected to fuel the growth of the market.
The availability of new and improved treatments for solid tumors is another key driver of market growth. For instance, immunotherapies, such as checkpoint inhibitors, are promising in treating various types of solid tumors. Additionally, targeted therapies targeting mutated genes that drive tumor growth are becoming more widely available. These advances in treatment are expected to result in better patient outcomes and drive market growth.

However, the high cost of treatment and side effects associated with some therapies are major restraints on the market growth. Additionally, the lack of awareness about early detection and available treatments is a challenge in developing countries.

Regional Outlook:

Currently, North America holds a 33.6% market share in the regional segment of the solid tumour cancer treatment market. According to the most recent data provided by the Centers for Disease Control and Prevention (CDC), the number of new cancer cases in the United States will increase by 24% in men, amounting to 1 million cases per year, and by 21% in women, amounting to 900,000 cases per year, over the next 10 years, from 2010 to 2020. Domicile of major players such as AstraZeneca, Merck & Co., Inc., and Amgen, Inc., among others, will further stimulate market expansion in the region. Due to the supportive regulatory environment provided by the European Medical Agency (EMA) for developing and selling pharmacological medicines used in the treatment of solid tumour cancer, Europe holds a 30.2% market share. In addition, a favourable reimbursement scenario reinforces market expansion. Asia-share Pacific's market will increase to 19.5% during the forecast period due to rising public awareness of cancer and its treatment as well as a developing healthcare infrastructure.

Major Players Profiled in the Market Report:

The major players profiled in the market report are:
AstraZeneca, Plc.,
Amgen, Inc.,
B. Braun Melsungen AG,
Bristol Myers Squibb & Company,
Eli Lilly & Company,
F.Hoffman La-Roche Ltd.,
Merck & Co., Inc.,
Novartis AG, Pfizer, Inc.
Olympus Medical Systems.

Key Questions Answered In This Report:

Covid 19 impact analysis on global Solid Tumor Cancer Treatment industry.
What are the current market trends and dynamics in the Solid Tumor Cancer Treatment market and valuable opportunities for emerging players?
What is driving Solid Tumor Cancer Treatment market?
What are the key challenges to market growth?
Which segment accounts for the fastest CAGR during the forecast period?
Which product type segment holds a larger market share and why?
Are low and middle-income economies investing in the Solid Tumor Cancer Treatment market?
Key growth pockets on the basis of regions, types, applications, and end-users
What is the market trend and dynamics in emerging markets such as Asia pacific, Latin America, and Middle East & Africa?

Unique data points of this report:

Statistics on Solid Tumor Cancer Treatment and spending worldwide
Recent trends across different regions in terms of adoption of Solid Tumor Cancer Treatment across industries
Notable developments going on in the industry
Attractive investment proposition for segments as well as geography
Comparative scenario for all the segments for years 2018 (actual) and 2028 (forecast)

Table of Content:

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global STCT Market Portraiture
2.2. Global STCT Market, by Indication, 2018 (US$ Bn)
2.3. Global STCT Market, by Therapy, 2018 (US$ Bn)
2.4. Global STCT Market, by Geography, 2018 (US$ Bn)

Chapter 3. Solid Tumor Cancer Treatment (STCT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global STCT Market, by Key Players, 2018

Chapter 4. Global Solid Tumor Cancer Treatment (STCT) Market, by Indication
4.1. Overview
4.2. Breast Cancer
4.3. Cervical Cancer
4.4. Colorectal Cancer
4.5. Lung Cancer
4.6. Prostate Cancer
4.7. Others (Brain Tumor, Pancreatic Cancer etc.)

Chapter 5. Global Solid Tumor Cancer Treatment (STCT) Market, by Therapy
5.1. Chemotherapy
5.2. Targeted Therapy
5.3. Immunotherapy
5.4. Hormone Therapy
5.5. Surgical Procedures
…………..Continued

*More companies can be added in Detailed Report.

Access the complete market research report here - https://douglasinsights.com/solid-tumor-cancer-treatment-market

The Tell-Tale Signs That Cara Delevingne Has Been In Need Of Help for a Long Time - https://douglasinsights.com/blog/the-tell-tale-signs-that-cara-delevingne-has-been-in-need-of-help-for-a-long-time

About Douglas Insights-

Douglas insights UK limited is the first company to provide comparison of market research reports by table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.

Recently added research reports @ Douglas Insights-

Tumor Necrosis Factor (TNF) Inhibitors Market- https://douglasinsights.com/tumor-necrosis-factor-tnf-inhibitors-market
Neuroendocrine Tumor Treatment Market - https://douglasinsights.com/neuroendocrine-tumor-treatment-market
Circulating Tumor Cells Prognostic Technologies Market - https://douglasinsights.com/circulating-tumor-cells-prognostic-technologies-market
Circulating Tumor Cell Diagnostics Market - https://douglasinsights.com/circulating-tumor-cell-diagnostics-market

Isabella Hawke
Douglas Insights
+44 7624 248772
isabella@douglasinsights.com
Visit us on social media:
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.